Company / SG&A per Share
Merck & Co. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.21
FY2025
5-year range
$3.73 / $4.25
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
#43 of 210
Health Care
What the data says
Merck & Co.'s sg&a per share of $4.21 is higher than 80% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $3.34 in FY2020 to $4.25 in FY2024.
Based on SEC 10-K filings.
4.21 in FY2025 with a 5-year CAGR of +4.7%. Top quartile in the Health Care sector.
Remained stable around $4.21 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.2%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 210This company $4.21 Sector average $40.75
▼
-89.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 1.0% year-over-year.
- Ranks #43 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.21 | -1.0% |
| FY2024 | $4.25 | +2.8% |
| FY2023 | $4.14 | +4.7% |
| FY2022 | $3.95 | +5.8% |
| FY2021 | $3.73 | +11.7% |
| FY2020 | $3.34 | -2.8% |
| FY2019 | $3.44 | -5.1% |
| FY2018 | $3.62 | +2.2% |
| FY2017 | $3.55 | +3.6% |
| FY2016 | $3.42 | -0.6% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026